DHR vs RTX: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and RTX Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
RTX Corporation · Industrials
$172.90
-21.3% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
RTX trades at a lower forward P/E
(32.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
RTX |
| Current Price |
$174.04 |
$172.90 |
| Fair Value Estimate |
$197.01 |
$136.05 |
| Upside to Fair Value |
+13.2%
|
-21.3%
|
| Market Cap |
$123.2B |
$232.8B |
| Forward P/E |
33.4x
|
32.1x
|
| EV / EBITDA |
20.3x
|
19.2x
|
| Price / Sales |
5.0x
|
2.6x
|
| Price / FCF |
23.3x
|
27.9x
|
| Revenue Growth YoY |
+3.7%
|
+8.7%
|
| Gross Margin |
60.7%
|
20.2%
|
| Operating Margin |
21.0%
|
10.4%
|
| Return on Equity |
7.1%
|
11.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
3.59%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
RTX Corporation is a leading aerospace and defense company with a diversified portfolio spanning Pratt & Whitney jet engines, Collins Aerospace avionics, and Raytheon Intelligence & Space defense systems. The company benefits from a strong competitive moat supported by a $271 billion backlog and multi-year contracts, driving consistent revenue growth of 10% in 2025 and 9% in Q1 2026. Earnings gro…
Accumulation Zones
| Metric |
DHR |
RTX |
| Zone Low |
$147.76 |
$102.04 |
| Zone High |
$167.46 |
$115.64 |
| In Buy Zone? |
No
|
No
|